Drug
Tivozanib Plus Folfox6
Tivozanib Plus Folfox6: highest development phase Phase 1, developed by Aveo Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aveo Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tivozanib (AV-951) plus FOLFOX6 NCT00660153 | Phase 1 | Colorectal Cancer |
Latest
No recent events.
Follow Tivozanib Plus Folfox6 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.